Physician profile
Daniel Mok
NPI 1932786258
$9,850.29
in general payments reported to CMS, 2019-2025
9 companies · $9,369 in 2025
The $9,369 reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $392 · 2024: $89.33 · 2025: $9,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,583 · Food and Beverage: $1,595 · Travel and Lodging: $532 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,583.33 |
| Food and Beverage | $1,594.69 |
| Travel and Lodging | $532.31 |
| Education | $139.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,681.44 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $3,000.00 | 2025 | Infinity |
| Medtronic, INC. | $1,533.40 | 2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $844.24 | 2025 | Senza |
| Ipsen Biopharmaceuticals, INC | $399.86 | 2023-2025 | Dysport |
| Spr Therapeutics, INC | $155.14 | 2024-2025 | Sprint Pns System |
| Mml US, INC. | $96.25 | 2025 | Reactiv8 |
| Merz Pharmaceuticals, LLC | $85.00 | 2023 | |
| Abbvie INC. | $54.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.